Literature DB >> 8726002

Modulatory effect of antibiotics on cytokine production by human monocytes in vitro.

K Morikawa1, H Watabe, M Araake, S Morikawa.   

Abstract

Some antimicrobial agents have been reported to modify the host immune and inflammatory responses both in vivo and in vitro. Fosfomycin (FOM) and clarithromycin (CAM) have immunomodulatory activity on human lymphocyte function. In the present study, we examined the effects of FOM and CAM on cytokine synthesis by lipopolysaccharide (LPS)-stimulated human monocytes in comparison with that of dexamethasone in vitro. The three drugs demonstrated positive or negative effects on the synthesis of various cytokines by LPS-primed monocytes. They suppressed the synthesis of tumor necrosis factor alpha, interleukin 1 alpha (IL-1 alpha), IL-1 beta, the IL-1 receptor antagonist, and granulocyte-macrophage colony-stimulating factor in a concentration-dependent manner at concentrations between 1.6 and 40 micrograms/ml. On the contrary, the drugs showed different actions on the synthesis of IL-6 and IL-10. Namely, FOM enhanced both IL-6 and IL-10 synthesis, CAM enhanced only IL-10 synthesis, but dexamethasone deeply suppressed the synthesis of both cytokines. These data indicate that antibacterial agents may modify acute-phase inflammatory responses through their effects on cytokine synthesis by monocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726002      PMCID: PMC163332          DOI: 10.1128/AAC.40.6.1366

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Effects of quinolones on tumor necrosis factor production by human monocytes.

Authors:  S Bailly; M Fay; Y Roche; M A Gougerot-Pocidalo
Journal:  Int J Immunopharmacol       Date:  1990

2.  Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages.

Authors:  K Takeshita; I Yamagishi; M Harada; S Otomo; T Nakagawa; Y Mizushima
Journal:  Drugs Exp Clin Res       Date:  1989

3.  Quinolone-induced differential modification of IL-1 alpha and IL-1 beta production by LPS-stimulated human monocytes.

Authors:  S Bailly; Y Mahe; B Ferrua; M Fay; T Tursz; H Wakasugi; M A Gougerot-Pocidalo
Journal:  Cell Immunol       Date:  1990-06       Impact factor: 4.868

4.  Immunomodulatory effect of fosfomycin on human B-lymphocyte function.

Authors:  K Morikawa; F Oseko; S Morikawa
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

5.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

6.  Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alpha.

Authors:  S Bailly; M Fay; B Ferrua; M A Gougerot-Pocidalo
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

7.  Dexamethasone regulation of the expression of cytokine mRNAs induced by interleukin-1 in the astrocytoma cell line U373MG.

Authors:  T Nishida; S Nakai; T Kawakami; K Aihara; N Nishino; Y Hirai
Journal:  FEBS Lett       Date:  1989-01-16       Impact factor: 4.124

8.  Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro.

Authors:  Y Iino; M Toriyama; K Kudo; Y Natori; A Yuo
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1992-10

9.  Interleukin 10 protects mice from lethal endotoxemia.

Authors:  M Howard; T Muchamuel; S Andrade; S Menon
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  51 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  The role of CD 14-associated molecules in the immunomodulating activity of chorionic gonadotropin.

Authors:  S V Shirshev; S A Zamorina
Journal:  Dokl Biol Sci       Date:  2004 Mar-Apr

3.  The effect of chorionic gonadotropin on APO-A1 synthesis by the peripheral blood monocytes. The role of female estrogenic hormones and L-type Ca2+-channels.

Authors:  S V Shirshev; S A Zamorina
Journal:  Dokl Biochem Biophys       Date:  2005 May-Jun       Impact factor: 0.788

4.  Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors.

Authors:  Leigh A Jones; Jean-Paul Anthony; Fiona L Henriquez; Russell E Lyons; Mohammad B Nickdel; Katharine C Carter; James Alexander; Craig W Roberts
Journal:  Immunology       Date:  2008-03-28       Impact factor: 7.397

5.  Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice.

Authors:  M Duong; M Simard; Y Bergeron; N Ouellet; M Côté-Richer; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

6.  Reply to "Bacterial Proliferation May Be the Key Component of Sepsis Mortality".

Authors:  Antonio De Maio
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

7.  Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors.

Authors:  Jibran Ahmed; Arun Kumar; Kaushal Parikh; Asad Anwar; Bettina M Knoll; Carmelo Puccio; Hoo Chun; Michael Fanucchi; Seah H Lim
Journal:  Oncoimmunology       Date:  2018-08-20       Impact factor: 8.110

8.  Effect of empiric antibiotic treatment on plasma endotoxin activity in septic patients.

Authors:  F Mignon; M Piagnerelli; M Van Nuffelen; J L Vincent
Journal:  Infection       Date:  2014-01-28       Impact factor: 3.553

9.  Evidence-based clinical practice guidelines for inflammatory bowel disease.

Authors:  Katsuyoshi Matsuoka; Taku Kobayashi; Fumiaki Ueno; Toshiyuki Matsui; Fumihito Hirai; Nagamu Inoue; Jun Kato; Kenji Kobayashi; Kiyonori Kobayashi; Kazutaka Koganei; Reiko Kunisaki; Satoshi Motoya; Masakazu Nagahori; Hiroshi Nakase; Fumio Omata; Masayuki Saruta; Toshiaki Watanabe; Toshiaki Tanaka; Takanori Kanai; Yoshinori Noguchi; Ken-Ichi Takahashi; Kenji Watanabe; Toshifumi Hibi; Yasuo Suzuki; Mamoru Watanabe; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2018-02-10       Impact factor: 7.527

10.  Inhibition of secretion of interleukin-1alpha and tumor necrosis factor alpha by the ketolide antibiotic telithromycin.

Authors:  Fausto G Araujo; Teri L Slifer; Jack S Remington
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.